Shuttle Pharma raises $4.25M in private placement of common stock and pre-funded warrants

Shuttle Pharmaceuticals Holdings, Inc.

• Gross proceeds of $4.25M from sale of 21,924 shares and 1,158,953 pre-funded warrants at $3.60 per unit.
• Pre-funded warrants exercisable immediately at $0.001 per share, expiring when fully exercised.
• Net proceeds to be used for potential acquisitions, marketing, and general corporate purposes.
• WestPark Capital acted as exclusive placement agent with a 4% fee of gross proceeds.
• Company agreed to file resale registration statement within 10 days; lock-up on further issuances for up to 120 days.